fenofibrate 200 mg for heart disease risk | STERIS HEALTHCARE PVT LTD, Navi Mumbai

Elagolix 200 mg | ELIGOLUX 200

ELIGOLUX 200 is a prescription medication formulated with Elagolix 200 mg, a gonadotropin-releasing hormone (GnRH) receptor antagonist. This innovative drug is primarily used in the management of moderate to severe pain associated with endometriosis, a condition in which tissue similar to the uterine lining grows outside the uterus, causing chronic pelvic pain and menstrual irregularities. ELIGOLUX 200 works by suppressing the production of ovarian hormones, particularly estrogen, which helps reduce endometriosis-related pain and improves quality of life for women experiencing this condition. Manufactured under strict quality standards, ELIGOLUX 200 ensures safety, efficacy, and consistent therapeutic outcomes. Uses ELIGOLUX 200 is indicated for the management of symptoms related to endometriosis, including: Moderate to severe pelvic pain associated with endometriosis. Dysmenorrhea (painful menstrual periods) caused by endometriosis. Non-menstrual pelvic pain and discomfort associated with endometrial lesions. In some cases, it may be used under medical supervision to reduce reliance on surgical interventions for pain management. By targeting the hormonal pathway that contributes to endometriosis, ELIGOLUX 200 helps control symptoms effectively without affecting other body systems significantly. Benefits Taking ELIGOLUX 200 under the supervision of a healthcare professional provides several advantages: Significant Pain Relief: Reduces pelvic and menstrual pain associated with endometriosis. Improved Quality of Life: Allows patients to perform daily activities with reduced discomfort. Non-Surgical Option: Offers an alternative to surgery for managing endometriosis-related pain. Hormonal Regulation: Suppresses estrogen levels temporarily to prevent growth and inflammation of endometrial tissue. Clinically Supported: Elagolix has been studied in multiple clinical trials demonstrating its efficacy and safety in endometriosis management. ELIGOLUX 200 provides targeted symptom management, making it a preferred choice for women seeking relief from chronic endometriosis pain. Dosage ELIGOLUX 200 should be taken strictly according to a doctor’s prescription. Typical dosing guidelines include: Standard Dose: One Elagolix 200 mg tablet once or twice daily, depending on the severity of symptoms and physician recommendation. Administration: Tablets should be swallowed whole with water, with or without food. Treatment Duration: Usually prescribed for 6 months, though your doctor may adjust the duration based on response and side effect profile. Important: Avoid altering the dose or frequency without consulting a healthcare provider, as it may reduce effectiveness or increase the risk of side effects. Side Effects While ELIGOLUX 200 is generally well-tolerated, some patients may experience mild to moderate side effects, such as: Hot flashes or night sweats Headache or dizziness Nausea Decreased bone mineral density with long-term use Mood changes or fatigue Serious side effects are rare but may include severe liver issues or allergic reactions. Regular monitoring, including bone health assessments, may be advised during extended therapy. Precautions and Warning To ensure safe use of ELIGOLUX 200, observe the following precautions: Pregnancy & Breastfeeding: Avoid use during pregnancy. Women of childbearing potential should use effective contraception. Consult your doctor if breastfeeding. Bone Health: Long-term use may reduce bone mineral density; consider calcium and vitamin D supplementation. Medical Conditions: Inform your doctor if you have liver disease, osteoporosis, or other hormonal disorders. Drug Interactions: Avoid combining with other hormonal medications unless approved by a physician. Follow-Up: Regular medical check-ups are recommended to monitor response and side effects. Adhering to these precautions ensures optimal therapeutic benefit while minimizing risks associated with hormone suppression. Conclusion ELIGOLUX 200 – Elagolix Tablets 200 mg is a targeted therapy for managing moderate to severe endometriosis-related pain. By temporarily suppressing ovarian hormone production, it provides effective pain relief, improves daily functioning, and reduces the need for surgical interventions in many cases. Manufactured under strict quality standards by healthcare professionals, ELIGOLUX 200 is a trusted option for women seeking safe, reliable, and clinically supported endometriosis management. Following prescribed dosage, monitoring, and medical guidance ensures maximum benefit with minimal risk, helping patients regain comfort and quality of life.